(CLDX) Celldex Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Celldex Therapeutics | (CLDX) share price targets
Complete technical analysis of Celldex Therapeutics (CLDX) by charts plus indicators, forecast predictions and share price targets for Celldex Therapeutics (CLDX)
Celldex Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2026-02-06 View latest technical analysis
10 day averaged volume of Celldex Therapeutics is 630610
| Date | Daily Closing Price | Open | High | Low | Volume |
| 06 Fri Feb 2026 | 23.76 | 23.15 | 23.98 | 22.33 | 1.298 times |
| 05 Thu Feb 2026 | 22.58 | 24.04 | 24.34 | 22.55 | 1.932 times |
| 04 Wed Feb 2026 | 24.27 | 25.32 | 25.33 | 24.02 | 0.948 times |
| 03 Tue Feb 2026 | 25.17 | 24.72 | 25.60 | 24.68 | 1.297 times |
| 02 Mon Feb 2026 | 24.66 | 24.60 | 25.15 | 24.37 | 1.168 times |
| 30 Fri Jan 2026 | 24.60 | 24.39 | 24.99 | 23.95 | 0.901 times |
| 29 Thu Jan 2026 | 24.69 | 24.73 | 25.10 | 24.37 | 0.636 times |
| 28 Wed Jan 2026 | 24.77 | 26.21 | 26.21 | 24.58 | 0.57 times |
| 27 Tue Jan 2026 | 26.23 | 26.56 | 26.86 | 25.94 | 0.55 times |
| 26 Mon Jan 2026 | 26.57 | 25.57 | 26.75 | 25.40 | 1.425 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 24.3, but if it comes above 24.3, then a intra day buy could be more profitable.
If you take a sell trade below 24.3, then use 24.3 as stoploss and 23 as target. However if you take a buy trade in stock , then use 24.3 as stoploss and 25.4 as target.
Share price targets for Celldex Therapeutics (CLDX)
| Target Type | Value |
| Downside Target | 22.10 |
| Upside Target | 23.95 |
| Upside Target | 24.49 |
| Upside Target | 26.86 |
| Upside Target | 26.96 |
| Upside Target | 27.06 |
| Upside Target | 27.20 |
| Upside Target | 28.27 |
| Upside Target | 28.59 |
| Upside Target | 30.50 |
Intraday share price targets for Celldex Therapeutics (CLDX)
| Target Type | Value |
| Downside Intraday Target | 22.19 |
| Downside Intraday Target | 20.63 |
| Upside Intraday Target | 25.46 |
| Upside Intraday Target | 27.17 |
| Upside Intraday Target | 23.9 |
Weekly technical analysis of Celldex Therapeutics (CLDX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 06 Fri Feb 2026 | 23.76 | 24.60 | 25.60 | 22.33 | 1.627 times |
| 30 Fri Jan 2026 | 24.60 | 25.57 | 26.86 | 23.95 | 1.663 times |
| 23 Fri Jan 2026 | 25.92 | 25.44 | 26.96 | 25.00 | 0.338 times |
| 16 Fri Jan 2026 | 25.65 | 27.20 | 27.20 | 25.15 | 1.305 times |
| 09 Fri Jan 2026 | 27.38 | 27.04 | 28.27 | 25.15 | 1.038 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Celldex Therapeutics (CLDX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 06 Fri Feb 2026 | 23.76 | 24.60 | 25.60 | 22.33 | 0.317 times |
| 30 Fri Jan 2026 | 24.60 | 26.91 | 28.27 | 23.95 | 0.772 times |
| 31 Wed Dec 2025 | 27.16 | 26.60 | 30.50 | 24.97 | 1.155 times |
| 28 Fri Nov 2025 | 27.02 | 24.00 | 27.06 | 22.10 | 0.729 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Celldex Therapeutics (CLDX)
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term and the sell signal is strong.
Celldex Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Celldex Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Celldex Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.54 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Celldex Therapeutics ( (CLDX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Celldex Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Celldex Therapeutics in short term and the sell signal is strong.
Celldex Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Celldex Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Celldex Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 24.54 and Celldex Therapeutics (CLDX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Celldex Therapeutics (CLDX) stock. Volume based technical analysis of Celldex Therapeutics (CLDX) stock is negative.
Celldex Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

